EN2201(3H): CLL, SLL & Hairy Cell Leukemia

Overview
Register
Faculty
Tests

Instructions

Date & Location

Wednesday, September 1, 2021, 12:00 AM - Thursday, December 1, 2022, 12:00 AM

Credits

AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician (1.00 hours)

Accreditation

Accreditation with Commendation: The University of Washington School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation: The University of Washington School of Medicine designates this Enduring Material for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Keywords:

Mitigation of Relevant Financial Relationships

University of Washington School of Medicine adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Mazyar Shadman, MD, MPH
Associate Professor
Department of Medicine, Hematology and Oncology
Associate Professor, Clinical Research Division, Fred Hutch
Innovators Network Endowed Chair, Fred Hutch
Medical Director, Bezos Family Immunotherapy Clinic, Fred Hutch
Physician, Fred
University of Washington, Fred Hutchinson Cancer Research Center
Seattle, WA

CLL, SLL & Hairy Cell Leukemia by Mazyar Shadman, MD, MPH

METHOD OF PARTICIPATION

To complete this training, access to the internet is required. You must receive a minimum passing score of 80% on the post-test (max. 3 attempts) to receive your CME credit. Each module will have a required pre-test, educational component, and post-test. If after three (3) attempts you are unsuccessful, you will be ineligible to receive CME credit and MOC for the module. However, content will always be available to you. It is important to know that once you have started the Post-Test (Examination), if you exit the Post-Test without responding to all questions, it will be counted as a failed attempt.

DATE

Original Release: September 1, 2021

Termination Date: November 30, 2022

ACCREDITATION STATEMENT

The University of Washington School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Washington School of Medicine designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MAINTENANCE OF CERTIFICATION (MOC) CREDITS:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

The University of Washington School of Medicine gratefully acknowledges receipt of educational grant funds in support of this CME activity from: AbbVie

SPEAKER & COURSE PLANNER DISCLOSURES

Mazyar Shadman, MD, MPH: Advisory Boards/Consulting: Abbvie, Genentech, AstraZeneca, Sound Biologics, Pharmacyclics, Beigene, Bristol Myers Squibb, Morphosys, TG Therapeutics, Innate Pharma, Kite Pharma, Adaptive Biotechnologies, Epizyme, Eli Lilly, Atara Biotherapeutics; Grant/Research Support: Mustang Bio, Celgene, Bristol Myers Squibb, Pharmacyclics, Gilead, Genentech, Abbvie, TG Therapeutics, Beigene, AstraZeneca, Sunesis, Atara Biotherapeutics, GenMab
Andrew Coveler, MD (Course Co-Chair/Planner/Reviewer/Speaker): no relevant financial relationships to disclose
Ryan Cassaday, MD (Course Co-Chair/Planner/Reviewer/Speaker): Honoraria, Consulting/Speaking/Teaching, Advisory Committees/Review Panels and/or Grant/Research Support: Amgen, Kite/Gilead, Merck, Pepromene Bio, Pfizer, Vanda Pharmaceuticals
David Zhen, MD (Course Reviewer/Speaker): Advisory Committees and/or Review Panels: QED Therapeutics

All relevant financial relationships have been mitigated.

PDF of Presentation

Purchase